It’s hardly big news that CBD doesn’t get you high. And we’ve known for a while that CBD can also offset THC’s psychoactivity. But new research out
GW Pharmaceuticals created the first FDA-approved CBD-based drug, Epidiolex. Now, the company is turning its attention from seizure disorders to autism. The cannabis pharmaceutical company is currently conducting
This week the Arthritis Foundation became the first major health organization to issue guidance for using CBD as a treatment for arthritis pain. The foundation created the
Vaping continued to be big news this week, with spiked CBD e-pens taking center stage. The Associated Press published the findings of their own investigation into spiked
The perils of vaping have suddenly become very big news in the US, with six deaths and several hundred possible cases of lung illness associated with e-cigarettes.
If you live in California, you’ll probably have to wait a bit longer to buy CBD edibles in stores. A proposed bill, which would have reversed a
Technically, summer lasts a few more weeks in the northern hemisphere. But for many of us, Labor Day is the last holiday weekend that we can spend
It took almost eight months to get around to it, but the US Drug Enforcement Agency (DEA) has finally updated its guidance on hemp.
Setting a national THC testing standard is causing a major headache for the USDA. According to William Richmond, head of the Specialty Crops Program in the USDA’s
At this week’s National Industrial Hemp Council’s 2019 Hemp Business Summit, FDA Principal Associate Commissioner for Policy Lowell Schiller gave insight into the FDA’s current stance on
SHARE
This Week in CBD: October 11, 2019